Literature DB >> 1620621

Complete nucleotide sequence of a neuropathogenic variant of Friend murine leukemia virus PVC-211.

M P Remington1, P M Hoffman, S K Ruscetti, M Masuda.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1620621      PMCID： PMC312465          DOI： 10.1093/nar/20.12.3249

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  5 in total

1.  Complete nucleotide sequence of Friend murine leukemia virus, strain FB29.

Authors:  S Perryman; J Nishio; B Chesebro
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

2.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

3.  env-Related leukemogenic genes (gp55 genes) of two closely related polycythemic strains of Friend spleen focus-forming virus possess different recombination points with an endogenous mink cell focus-forming virus env gene.

Authors:  M Obata; H Amanuma; Y Harada; N Sagata; Y Ikawa
Journal:  Virology       Date:  1984-07-30       Impact factor: 3.616

4.  Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.

Authors:  M Masuda; M P Remington; P M Hoffman; S K Ruscetti
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Isolation of paralysis-inducing murine leukemia viruses from Friend virus passaged in rats.

Authors:  K Kai; T Furuta
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103
  5 in total
  10 in total

1.  Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus.

Authors:  L M Bundy; H Fan
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Capillary endothelial cell tropism of PVC-211 murine leukemia virus and its application for gene transduction.

Authors:  M Masuda; C A Hanson; N V Dugger; D S Robbins; S G Wilt; S K Ruscetti; P M Hoffman
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Brain infection by neuroinvasive but avirulent murine oncornaviruses.

Authors:  S Asković; F J McAtee; C Favara; J L Portis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Immunogenic determinants of a neuropathogenic murine leukemia virus.

Authors:  D S Robbins; M P Remington; M Sarzotti; D St Louis; P M Hoffman
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Cloning of E6 and E7 genes of human papilloma virus type 18 and transformation potential of E7 gene and its mutants.

Authors:  M Laassri; L Gul'ko; S Vinokurova; N Kisseljova; V Veiko; F Kisseljov
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

6.  Novel host range and cytopathic variant of ecotropic Friend murine leukemia virus.

Authors:  Yong Tae Jung; Tiyun Wu; Christine A Kozak
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Analysis of the unique hamster cell tropism of ecotropic murine leukemia virus PVC-211.

Authors:  M Masuda; M Masuda; C A Hanson; P M Hoffman; S K Ruscetti
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  The entire nucleotide sequence of friend-related and paralysis-inducing PVC-441 murine leukemia virus (MuLV) and its comparison with those of PVC-211 MuLV and Friend MuLV.

Authors:  A Tanaka; K Oka; K Tanaka; A Jinno; S K Ruscetti; K Kai
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Viral determinants that control the neuropathogenicity of PVC-211 murine leukemia virus in vivo determine brain capillary endothelial cell tropism of the virus in vitro.

Authors:  M Masuda; P M Hoffman; S K Ruscetti
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.

Authors:  H Y Dai; A Faxvaag; G I Troseth; H Aarset; A Dalen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.